Massachusetts General Hospital
Boston, MA, United States
Dr. Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff of the MGH he has authored over 200 original articles, reviews, and editorials on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. He also has a long-standing interest in the organ-sparing management of bladder cancer. More recently he has been writing and speaking about evidence development in oncology and the relationship between economy and culture on the one hand and the practice of radiation oncology on the other.
He is currently Shipley Professor of Radiation Oncology at Harvard Medical School and is past-President and Chair of ASTRO. He has a deep interest in medical education and serves as a program director for the Harvard Radiation Oncology Residency Program and has been a Trustee of the American Board of Radiology. Since 2011, has been the Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics. In 2016 he was a recipient of the ASTRO Gold Medal.
Disclosures:
Honorary Member Tribute to Laura Thevenot
Tuesday, October 1, 2024
10:25 AM – 10:29 AM ET